Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE study
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.119563 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Hartej Gill und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto,…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Reward, Desvenlafaxine Succinate, Selective Serotonin Reuptake Inhibitors. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H Lundbeck A/S.
Abstract (Originalsprache)
BACKGROUND: Anhedonia is a hallmark symptom of major depressive disorder (MDD), associated with impairments in various aspects of reward. VIVRE is the first study in patients with MDD receiving antidepressant therapy to include longitudinal assessment of reward behavior using the Effort-Expenditure for Rewards Task (EEfRT), a validated behavioral paradigm for the objective assessment of reward and effort-based decision-making in patients with MDD. METHODS: Randomized, double-blind study of vortioxetine (10 or 20 mg/day) versus desvenlafaxine (50 mg/day) in adults with MDD and partial response to selective serotonin reuptake inhibitor monotherapy. Motivation for reward based on the proportion of hard trial choices was assessed at baseline and after 8 weeks of treatment. RESULTS: There was no difference in the proportion of hard trial choices between the vortioxetine (n = 288) and desvenlafaxine (n = 300) treatment groups at baseline. Minimal change in parameters of reward motivation was seen over the 8-week treatment period in either group. The between-group difference in the proportion of hard trial choices at week 8 was not statistically significant (odds ratio: 0.97 [95 % CI: 0.82, 1.14]; P = 0.72). Similar results were obtained when controlling for reward probability, reward magnitude, trial number, and sex, or when limiting to the first 50 trials (excluding computer-selected trials). LIMITATIONS: Exploratory analyses evaluating the utility of the EEfRT in clinical populations. CONCLUSIONS: Experience from the VIVRE study suggests that further research is required to fully determine the clinical utility of the EEfRT for assessment of antidepressant treatment effects in patients with MDD. TRIAL REGISTRATION: NCT04448431.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
- Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: roger.mcintyre@bcdf.org.
- H. Lundbeck, Valby, Denmark.
Förderung
- H Lundbeck A/S
Zitieren
APA
Gill, H., McIntyre, R. S., & Christensen, M. C. (2025). Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119563
Vancouver
Gill H, McIntyre RS, Christensen MC. Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE study. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119563
BibTeX
@article{Gill2025,
author = {Gill, Hartej and McIntyre, Roger S and Christensen, Michael Cronquist},
title = {Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE study},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.119563}
}
EUVIMED